DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma
Recruiting · NCT06933836 · Observational (researchers observe without assigning treatment) · Lead sponsor: Barnet Dulaney Perkins Eye Centers
View the official record on ClinicalTrials.gov →Interventions studied
DSLT enables newly diagnosed patients to remain well controlled and off medications
What this trial is about
DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.
Who can take part
Age range
30 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Primary open angle glaucoma
- Patients age 30 or greater with an IOP of 18-26 mmHg
- Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines)
- DSLT procedure
Exclusion criteria
- History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery
- Angle closure patients
- Ocular Hypertension
- Baseline VF MD of worse than -12dB
- Uncontrolled systemic microvascular disease (eg. HTN, DM)
- Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)
Where it is running
1 location listed across 1 US state.
- Barnet Dulaney Perkins Eye Centers - Mesa, Arizona, United States